Genetic analysis showed that homozygosity for pathogenic WFS1 variants was overrepresented across all symptom categories (≥62%), reaching the highest levels in cognitive decline (81%), anosmia (78%), and adiadochokinesia (82%). This evidence concerns the gene WFS1 and Kallmann syndrome.